title: The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.
authors.affiliation: European Medicines Agency, 30 Churchill Place, London, E145EU, UK, priya.bahri@ema.europa.eu.
authors.forename: Priya
authors.initials: P
authors.lastname: Bahri
authors.forename: Alexander N
authors.initials: AN
authors.lastname: Dodoo
authors.forename: Brian D
authors.initials: BD
authors.lastname: Edwards
authors.forename: I Ralph
authors.initials: IR
authors.lastname: Edwards
authors.forename: Irene
authors.initials: I
authors.lastname: Fermont
authors.forename: Ulrich
authors.initials: U
authors.lastname: Hagemann
authors.forename: Kenneth
authors.initials: K
authors.lastname: Hartigan-Go
authors.forename: Bruce
authors.initials: B
authors.lastname: Hugman
authors.forename: Peter G
authors.initials: PG
authors.lastname: Mol
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D003142:Communication; D003257:Consumer Product Safety; D003299:Cooperative Behavior; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D007391:International Cooperation; D061214:Patient Safety; D060735:Pharmacovigilance; D016730:Program Development; D018570:Risk Assessment; D012307:Risk Factors; D012955:Societies, Medical